![Karen Felsmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Karen Felsmann worked as the Head-Development at SIRS-Lab GmbH from 2005 to 2013.
Eerdere bekende functies van Karen Felsmann
Bedrijven | Functie | Einde |
---|---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Corporate Officer/Principal | 07-05-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Health Technology |